|
    ATTBF U.S.: OTC

    Abattis Bioceuticals Corp.

    ATTBFUS
    Closed
    Last Updated: Sep 17, 2021 3:44 p.m. EDT Delayed quote

    $ 0.0070

    -0.0010 -12.50%
    Previous Close
    $0.0080
    Advanced Charting
    Volume: 382.47K 65 Day Avg: 306.97K
    125% vs Avg
    0.0068 Day Range 0.0085
    0.0041 52 Week Range 0.0575

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ATTBF Overview

    Performance

    5 Day
    • -28.57%
    1 Month
    • -39.39%
    3 Month
    • -53.33%
    YTD
    • -44.00%
    1 Year
    • 6.06%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 1 Full Ratings

    Recent News

    No Headlines Available

    No Headlines Available

    Abattis Bioceuticals Corp.

    Abattis Bioceuticals Corp. engages in the aggregation, integration, and investment in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. It produces, markets, and licenses proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic, and animal nutrition markets. The company was founded on June 30, 1997 and is headquartered in Vancouver, Canada.

    Competitors

    Name Chg % Market Cap
    Ono Pharmaceutical Co. Ltd. ADR 0.85% $12.27B
    Omeros Corp. 1.40% $998.68M
    Competitor Data Provided ByCapital Cube Logo